Skip to main content

Table 5 Relationship between AGO scorea and complete resection at secondary cytoreductive surgery

From: Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancer

 

Complete resectionb

Total

No (R1,R2)

Yes (R0)

AGO score

 negative

13 (59.1%)

20 (35.1%)

33

 positive

9 (40.9%)

37 (64.9%)

46

Total

22

57

79

  1. AGO score assessment had a sensitivity, specificity, positive predictive value, and negative predictive value of 64.9, 59.1, 80.4, and 39.4%, respectively
  2. aAGO score, Arbeitsgemeinschaft Gynäkologische Onkologie score
  3. bThe level of residual disease after SCS was divided into no gross (R0), 1–9 mm (R1), and equal to or more than 10 mm residual disease (R2)
Back to article page

Journal of Ovarian Research

ISSN: 1757-2215

Contact us